Cardiovascular risk associated with serum potassium in the context of mineralocorticoid receptor antagonist use in patients with heart failure and left ventricular dysfunction.

Rossignol, Patrick; Duarte, Kevin; Girerd, Nicolas; Karoui, Moez; McMurray, John JV; Swedberg, Karl; van Veldhuisen, Dirk J; Pocock, Stuart; Dickstein, Kenneth; Zannad, Faiez; +1 more... Pitt, Bertram; (2020) Cardiovascular risk associated with serum potassium in the context of mineralocorticoid receptor antagonist use in patients with heart failure and left ventricular dysfunction. European journal of heart failure, 22 (8). pp. 1402-1411. ISSN 1388-9842 DOI: https://doi.org/10.1002/ejhf.1724

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1002/ejhf.1724

Abstract

Item Type Article
Faculty and Department Faculty of Epidemiology and Population Health > Dept of Medical Statistics
PubMed ID 31919958
Elements ID 144304

Share

Download

Filename: ManuscriptRISKSCOREOCT 26 PRL CLEAN VERSION for submission jan 14 .docx

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar